• Year Founded: 2017
• Headquarters: Shanghai,China
• Estimated Employees: N/A
• Product Lines:
  • Fluorescent PCR nucleic acid detection kit for influenza
  • Pathogen Sequencing Kit
  • Nuclei acid extraction kit（paramagnetic particle method）
• Products:
  • Fluorescence PCR detection kits
  • Nucleic acid extraction kit
  • Fast Test Panel of 15 Respiratory Pathogens
  • Full Test Panel of 30 respiratory Pathogens
  • Virus Sampling Kit/Virus Transport Medium
  • Pathogen sequencing kit

Novel Coronavirus (2019-nCoV) Nucleic Acid Detection Kit(PCR-Fluorescence Probing)

BioGerm Nuclei acid extraction kit（paramagnetic particle method）

Virus Sampling Kit-Virus Transport Medium

Shanghai BioGerm Medical Technology Co., Ltd located in Shanghai Fengxian Fengchuang Valley, the main body of BioGerm has a 3000 square meters of clean plant which is used for the development and production of reagent andinstrument, used for technical service and standard GMP production.

The company’s wholly-owned medical laboratory is located in Pudong International Medical Park, covering an area of 1,000 square meters, which is already qualified for molecular genetics and microbial testing. It is a registered level 2 biosafety laboratory with the certification in both ISO 9001 and 13485.

At present, the company has applied for 23 patents, with three products have obtained the NMPA registration certificates and production licenses.

Four types of diagnostic kits related to respiratory infection have completed clinical trials and is expected to be available in China in the third quarter of this year. To make a deeper contribution to the field of respiratory pathogens and become a true "pathogen diagnostic expert".

BioGerm is building a high-throughput, fast, inexpensive and easy-to-use molecular pathogen detection technology platform. The platform technology will take only 15 minutes to complete the initial screening of respiratory pathogens, and the sensitivity and specificity of the analysis will be no less than that of traditional real-time fluorescent PCR reagents.

As of April 27, 2020, our products have been supplied to nearly a thousand medical agencies and laboratories in more than 30 provinces and cities nationwide. Besides, BioGerm's reagents have been exported with the national medical aid team to the United Kingdom, South Korea, Pakistan and other countries, and received the Certificate of Donation from the China Red Cross Foundation.

What’s more, our product was approved by the Brazilian National Health Surveillance Agency (ANVISA). All of these marks BioGerm's significant contribution to the prevention and control of epidemics worldwide.